1-AMINO-5-HALOGENOURACILS, PROCESS FOR THEIR PREPARATION, AND CENTRAL NERVOUS SYSTEM DEPRESSANTS CONTAINING SAME AS ACTIVE INGREDIENT
申请人:Yamasa Shoyu Kabushiki Kaisha also trading as Yamasa Corporation
公开号:EP0425669A1
公开(公告)日:1991-05-08
The invention relates to central nervous system depressants containing a 1-amino-5-halogenouracil represented by formula (I) (wherein X represents a halogen atom) or its salt as an active ingredient; 1-amino-5-halogenouracils represented by formula (II) (wherein X' represents chlorine, iodine or bromine) or salts thereof; and a process for preparing a 1-amino-5-halogenouracil represented by the above formula (I) from a pyramidine derivative represented by formula (III) (wherein X represents a halogen atom, and R represents a protective group).
本发明涉及含有由式(I)代表的1-氨基-5-卤素尿嘧啶(其中X代表卤素原子)或其盐作为活性成分的中枢神经系统抑制剂;由式(II)代表的1-氨基-5-卤素尿嘧啶(其中X'代表氯、碘或溴)或其盐;以及由式(III)代表的嘧啶衍生物(其中 X 代表卤素原子,R 代表保护基团)制备上式(I)代表的 1-氨基-5-卤代尿嘧啶的工艺。
ATARACTIC
申请人:Yamasa Shoyu Kabushiki Kaisha
公开号:EP0509098A1
公开(公告)日:1992-10-21
An ataractic containing as the active ingredient 1-amino-5-halogenouracil of general formula (I) or a pharmaceutically acceptable salt thereof. In the said formula X represents halogen.